Dr. Irem Kaymak earned her B.S. in molecular biology and genetics from the Middle East Technical University (in Turkey) and her Ph.D. in molecular biology and biochemistry from the University of Wuerzburg. During her graduate work she studied the function of protein phosphatase 4 (PP4C) in the mammalian circadian clock, before moving on to his doctorate which focused on the identification of metabolic liabilities in 3-D models of cancer. Her technical skills include mass spectrometry, 3-D cell culture models, and functional screening. In 2019, she joined the laboratory of Dr. Russell Jones at Van Andel Institute as a postdoctoral fellow.
The project investigates the metabolic and transcriptomic features of T cells in the exhaustion phase.
Ph.D. in molecular biology and Biochemistry, University of Wuerzburg (Advisor: Almut Schulze, Ph.D.)
Thesis: Identification of metabolic liabilities in 3-D models of cancer
B.S. in molecular biology and genetics, Middle East Technical University (Turkey)
German Excellence Initiative Research Fellowship for Ph.D. studies (2014-2017)
German Academic Exchange Service (DAAD) Fellowship for Master’s Degree (2011-2013)
The Scientific and Technological Research Council of Turkey, Undergraduate Scholarship (2006-2011)
To view a list of selected publications click below.
Floter J*, Kaymak I*, Schulze A. 2017. Regulation of metabolic activity by p53. Metabolites 7.
Ros S, Flöter J, Kaymak I, Da Costa C, Houddane A, Dubuis S, Griffiths B, Mitter R, Walz S, Blake S, Behrens A, Brindle KM, Zamboni N, Rider MH, Schulze A. 2017. 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells. Oncogene.